Research Program at Vance Thompson Vision

Vance Thompson Vision is currently recruiting for the following studies. The descriptions below highlight which patients within your program might be good candidates for the treatment types currently under investigation by Vance Thompson Vision and monitored by the FDA. For questions about any of these trials please call our Director of Research Keeley Puls at 605.371.7075

 

Cataract Research 

ACUFOCUS - Enrolling  Sioux Falls

Good Candidate: Patients 22 years of age and older with cataracts in both eyes.

About study: The purpose of this study is to determine if the IC-8 lens is safe and provides far, intermediate and near vision when compared to a standard monofocal or monofocal toric lens

Which eye: Both eyes in study.

How long is study: 1 year study

Number of visits: 12 visits over 1 year

Cost to patient: Insurance will be billed for a normal cataract surgery.

Compensation:  Subjects will be compensated for their participation in this study.

Co-management-  No co-management

Lead Contact- Sam Nielson  [email protected]     605-371-7049

 

RxSight LAL - Enrolling Sioux Falls

Good Candidate:  Patients 40-80 years of age  with cataract in both eyes who have had prior Lasik or PRK with clear ocular medium.

About study: The purpose of the study is to evaluate the safety and effectiveness of the LAL by comparing the results obtained with it to the results obtained with your eye implanted with the Sensar AR40e standard IOL

Which eye:  Both eyes in the study.

How long is study:  6 month study

Number of visits:   14 visits over 6 month

Cost to patient:  Insurance billed for normal cataract surgery.

Compensation:   Subjects will be compensated for their participation in this study.

Co-management: No co-management

Lead Contact: Melissa Holm    [email protected]   605-371-7081

Glaucoma Research

DES / iStent FDA monitored clinical trial - Enrolling - Sioux Falls 

Good Candidate:  Patients who are ready to undergo cataract surgery that have mild to moderate glaucoma. Subjects may have either standard or advanced cataract surgery.

About Study:  Purpose of the study is to determine if the use of trabecular meshwork bypass stent (iStent) in conjunction with cataract extraction will have a positive impact on ocular surface disease.

Which eye:   Both eyes will be enrolled in the study.

How long is study:

How many visits:  3 total visits

Cost to patient:  There is no additional cost to the patients. Patients will be responsible for normal Cataract surgery charges

Compensation: Subjects will be compensated for their participation in this study.

Co-management:   No co-management

Lead Contact:  Jason Meyer   [email protected]     605-371-7064

 

Glaucos GC-010 phase III FDA monitored clinical trial - Enrolling  Sioux Falls, Fargo, Bozeman

Good Candidate: Patients that are ocular hypertensive or have mild to moderate glaucoma and will not need cataract surgery in the next three years or have had cataract surgery and no prior glaucoma surgery.

About study: To compare the safety and initial efficacy of intraocular implants containing travoprost at two different elution rates versus Timolol Maleate Ophthalmic Solution, USP, 0.5% (timolol) in reducing elevated intraocular pressure in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Which eye:  Only one eye is eligible to participate in the study

How long is study:  3 year study

Number of visits:  16 visits over the 3 years

Cost to patient:  None

Compensation:  Subjects will be compensated for their participation in this study.

Co-management:  May co-manage non study eye if patient desires but we will watch both during the duration of the study as well.

Lead Contact- Kristin Dunne [email protected]    605-371-7037

 

Glaucos GC-011 - Enrolling Sioux Falls

Good Candidate:  Patients diagnosed with late stage open-angle glaucoma, having had previous surgical treatment (s) and are taking maximum medications to control the pressure.

About Study: The purpose of this study is to evaluate the safety and efficacy of an investigational (not approved by the FDA) medical device that is implanted into the eye and designed to reduce eye pressure in patients with your condition

Which eye:  Only one eye will be enrolled in study.

How long is study: 1 year study

How many visits:  6 visits in 1 year. You doctor may ask you to be seen annually up to 5 years after you have been enrolled

Cost to patient:   No charge for study related visits before and after surgery.  Insurance billed for any medication you may need.

Compensation:  Subjects will be compensated for their participation in this study.

Co-management: May co-manage non study eye if patient desires but we will watch both during the duration of the study as well.

Lead Contact- Kristin Dunne [email protected]    605-371-7037

Aphakic Research

Artisan Aphakia IOL phase III FDA monitored clinical trial - Enrolling   Sioux Falls

Good Candidate:    Patient who is aphakic and has a compromised capsular bag.

About Study: ARTISAN Aphakia Lens is an intraocular lens that may correct aphakia

Which eye:  Both eyes are eligible to participate in the study

How long is study:  3 year study

How many visits:  9 visits over 3 years

Cost to patient: Patient responsible for all costs that are not covered by your insurance company.

Compensation:  None

Co-management:  No co-management

Lead Contact: Melissa Holm    [email protected]   605-371-7081

Presbyiobic Research

None at this time

Refractive Research

None at this time.

Dry Eye Research

None at this time.

Cornea Research

Avedro KXL - Enrolling  Sioux Falls

Good Candidate:  Patients 12 to 55 years of age who have been diagnosed with keratoconus that is progressing within the last 18 months.

About study:  The study may help the researchers to determine whether using the KXL light system and study eye drops on the cornea when the corneal epithelium is not removed is safe and effective in treating keratoconus.

Which eye:   Both eyes can be eligible but will be treated at different times

Number of visits:  9-15 visits (per eye enrolled) over 12 months

How long is study:  12 months

Cost to patient:   No charge to patient

Compensation:  

Co-management: No co-management

Lead Contact:  Jason Meyer   [email protected]     605-371-7064

 

closed to enrollment - ongoing studies

  • Sjogrens Dry Eye

  • Carl Zeiss IOL

  • B+L Dvisc

  • B&L - Viscosurgical Device
  • Alcon UV-Femtosecond Laser Assisted Lenticular Extraction
  • Glaukos - GC-009
  • Glaukos - GC-007
  • Teton
  • Denali
  • Glaukos - PAS
  • Sonata 2
  • Alcon Toric IOL, ORA